Zhejiang Ruibang Pharmaceutical Co., LTD
PublicLast Round
Series A
May 5, 2023
Total Funding Raised
$14.3M
Company Overview
Zhejiang Ruibang Pharmaceutical Co., LTD is a pharmaceutical company that manufactures and sells active pharmaceutical ingredients (APIs), finished drug products, and food additives.
AI Layer
Non-AI
Keywords
active pharmaceutical ingredientsAPIAPI manufacturingcontract development and manufacturingCDMOpharmaceutical manufacturingcyclosporinemupirocinfinished formulationsfood additivesnutraceutical ingredientspharma outsourcinggluconate saltspharmaceutical fermentationchemical synthesisimmunosuppressantsantibiotics
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Zhejiang Ruibang Pharmaceutical Co., LTD Comps
Public and private peers based on sector, stage, and business model.
Zhejiang Ruibang Pharmaceutical Co., LTD Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 5, 2023 |
Zhejiang Ruibang Pharmaceutical Co., LTD Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Guohua Energy Investment Co., Ltd. | Series A |
| SDIC Chuangyi Industrial Fund Management | Series A |
Zhejiang Ruibang Pharmaceutical Co., LTD Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Firmographic Details
Headquarters—
Employee Range6
Year Founded1956
Last FundingMay 5, 2023